Aditya Birla Sun Life Mutual Fund has lowered its stake in Strides Pharma Science Ltd to 3.49 percent, as disclosed in a recent regulatory filing. This represents a reduction of 2.06 percent in the mutual fund’s holding.
Previously, Aditya Birla Sun Life held 5.55 percent of Strides Pharma’s paid-up equity share capital, according to a disclosure dated December 7, 2018. The latest transaction, recorded on September 10, 2024, reduced the fund’s holding.
The updated shareholding details were revealed in an exchange filing made by Strides Pharma Science Ltd.
On the NSE, Strides Pharma’s stock was trading at Rs 1,358.60 per share, reflecting a 0.47 percent increase on the day. The company is recognized for its presence in the pharmaceutical sector.
The stock has posted significant gains in 2024, delivering a 106.94 percent return so far. Over the past year, the share price has surged by 190.68 percent.